Compounds > canertinib dihydrochloride
Page last updated: 2024-09-04

canertinib dihydrochloride and abt 869

canertinib dihydrochloride has been researched along with abt 869 in 1 studies

Compound Research Comparison

Studies
(canertinib dihydrochloride)		Trials
(canertinib dihydrochloride)		Recent Studies (post-2010)
(canertinib dihydrochloride)		Studies
(abt 869)		Trials
(abt 869)		Recent Studies (post-2010) (abt 869)
31136841559

Protein Interaction Comparison

ProteinTaxonomycanertinib dihydrochloride (IC50)abt 869 (IC50)
Aurora kinase AHomo sapiens (human)0.76
Cyclin-dependent kinase 1Homo sapiens (human)9.8
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)0.0321
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)1.9
Platelet-derived growth factor receptor betaHomo sapiens (human)0.0492
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.0313
Fibroblast growth factor receptor 1Homo sapiens (human)5.479
AromataseHomo sapiens (human)0.0418
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.015
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.0364
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.1309
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.0312
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.0126
Cyclin-dependent kinase 8Homo sapiens (human)2.158
Angiopoietin-1 receptorHomo sapiens (human)0.0601
Cyclin-dependent kinase 19Homo sapiens (human)0.024

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Russu, WA; Shallal, HM1

Other Studies

1 other study(ies) available for canertinib dihydrochloride and abt 869

ArticleYear
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship

2011